Cargando…
Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study
BACKGROUND: Canine Distemper Virus (CDV) and Canine Parvovirus (CPV) lead to infections with high mortality rates in dogs. These viruses affect unvaccinated dogs or dogs with incomplete vaccination protocols. Vaccination plays an important role in reducing death rates, preventing clinical cases and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240190/ https://www.ncbi.nlm.nih.gov/pubmed/30445957 http://dx.doi.org/10.1186/s12917-018-1673-z |
_version_ | 1783371591576453120 |
---|---|
author | Vila Nova, Beatriz Cunha, Eva Sepúlveda, Nuno Oliveira, Manuela São Braz, Berta Tavares, Luis Almeida, Virgílio Gil, Solange |
author_facet | Vila Nova, Beatriz Cunha, Eva Sepúlveda, Nuno Oliveira, Manuela São Braz, Berta Tavares, Luis Almeida, Virgílio Gil, Solange |
author_sort | Vila Nova, Beatriz |
collection | PubMed |
description | BACKGROUND: Canine Distemper Virus (CDV) and Canine Parvovirus (CPV) lead to infections with high mortality rates in dogs. These viruses affect unvaccinated dogs or dogs with incomplete vaccination protocols. Vaccination plays an important role in reducing death rates, preventing clinical cases and controlling the spread of virus However, the efficacy of vaccination might be affected by different factors including vaccine scheduling and the neutralization of the vaccine targets by maternal antibodies. In face of these factors, the main goals of this study are (i) to investigate the antibody responses of puppies undergoing different primary vaccination protocols against CPV and CDV and (ii) to estimate the time until seroreversion in adult dogs unvaccinated for at least 3 years. RESULTS: Antibody protection against CDV and CPV was evaluated in a total of 20 dogs: 5 puppies that initiated immunization at 6 weeks after birth (group A), 8 animals that started vaccination between 8 and 12 weeks of age (group B), and 7 adult dogs that have not been vaccinated for at least 3 years (group C). Blood samples were collected from each animal, with 3 to 4 weeks apart. Antibody responses were measured using indirect ELISA. In the second immunization point, no significant differences were found between the seroconversion of groups A and B for each viral infection (p = 0.81 and 0.20 for CDV and CPV, respectively). In the third immunization, there was evidence for a shorter time to achieve a protective titer against CPV in group B when compared to group A (p = 0.015). Similar evidence was not found for CDV (p-value = 0.41). In Group C, the average time until seroveversion was estimated at 2.86 years and 7.63 years for CDV and CPV, respectively. CONCLUSION: Vaccine response to CDV and CPV is specific in each individual. Effective immune protection in primary vaccination depends mainly on the initial titer of maternal antibodies acquired by the neonate. Other factors such as environmental exposure, immunization schedules and immune system activity influence the duration of immunity in adult dogs. The variability found reinforces the need to determine individual humoral immunity levels in order to assess vaccine efficacy. |
format | Online Article Text |
id | pubmed-6240190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62401902018-11-26 Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study Vila Nova, Beatriz Cunha, Eva Sepúlveda, Nuno Oliveira, Manuela São Braz, Berta Tavares, Luis Almeida, Virgílio Gil, Solange BMC Vet Res Research Article BACKGROUND: Canine Distemper Virus (CDV) and Canine Parvovirus (CPV) lead to infections with high mortality rates in dogs. These viruses affect unvaccinated dogs or dogs with incomplete vaccination protocols. Vaccination plays an important role in reducing death rates, preventing clinical cases and controlling the spread of virus However, the efficacy of vaccination might be affected by different factors including vaccine scheduling and the neutralization of the vaccine targets by maternal antibodies. In face of these factors, the main goals of this study are (i) to investigate the antibody responses of puppies undergoing different primary vaccination protocols against CPV and CDV and (ii) to estimate the time until seroreversion in adult dogs unvaccinated for at least 3 years. RESULTS: Antibody protection against CDV and CPV was evaluated in a total of 20 dogs: 5 puppies that initiated immunization at 6 weeks after birth (group A), 8 animals that started vaccination between 8 and 12 weeks of age (group B), and 7 adult dogs that have not been vaccinated for at least 3 years (group C). Blood samples were collected from each animal, with 3 to 4 weeks apart. Antibody responses were measured using indirect ELISA. In the second immunization point, no significant differences were found between the seroconversion of groups A and B for each viral infection (p = 0.81 and 0.20 for CDV and CPV, respectively). In the third immunization, there was evidence for a shorter time to achieve a protective titer against CPV in group B when compared to group A (p = 0.015). Similar evidence was not found for CDV (p-value = 0.41). In Group C, the average time until seroveversion was estimated at 2.86 years and 7.63 years for CDV and CPV, respectively. CONCLUSION: Vaccine response to CDV and CPV is specific in each individual. Effective immune protection in primary vaccination depends mainly on the initial titer of maternal antibodies acquired by the neonate. Other factors such as environmental exposure, immunization schedules and immune system activity influence the duration of immunity in adult dogs. The variability found reinforces the need to determine individual humoral immunity levels in order to assess vaccine efficacy. BioMed Central 2018-11-16 /pmc/articles/PMC6240190/ /pubmed/30445957 http://dx.doi.org/10.1186/s12917-018-1673-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Vila Nova, Beatriz Cunha, Eva Sepúlveda, Nuno Oliveira, Manuela São Braz, Berta Tavares, Luis Almeida, Virgílio Gil, Solange Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title | Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title_full | Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title_fullStr | Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title_full_unstemmed | Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title_short | Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
title_sort | evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240190/ https://www.ncbi.nlm.nih.gov/pubmed/30445957 http://dx.doi.org/10.1186/s12917-018-1673-z |
work_keys_str_mv | AT vilanovabeatriz evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT cunhaeva evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT sepulvedanuno evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT oliveiramanuela evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT saobrazberta evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT tavaresluis evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT almeidavirgilio evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy AT gilsolange evaluationofthehumoralimmuneresponseinducedbyvaccinationforcaninedistemperandparvovirusapilotstudy |